[KIC > 보수]
소개
목차
교육일정
Andrew Roddam(GSK)
RWD has significant potential to improve the efficiency of clinical trials, yet challenges remain. This presentation will explore the use of data driven protocol design tools, RWD to aid country and site selection, and utilization of direct from EHR data capture tools. I will also explore the potential to use RWD as potential comparator arms for clinical trials. For each opportunity I will highlight both the opportunity presented alongside some of the barriers that remain.
● Enhancing Clinical Development through the Use of RWD
Bruce Crawford(Syneos Health)
Real world data and evidence can help support product development throughout the entire lifecycle. However, it is important to conduct RWE as a targeted approach by balancing evidence generation and stakeholder needs. This presentation will provide an overview of the use of RWE throughout the development process with a focus on:
? Ensure that at product launch there are no impediments to reimbursement and return on investment (ROI) can therefore be maximized
? An Integrated Evidence Plan must be in place that has clearly identified the evidence gaps for not only the Regulator but also Payers, Patients and Physicians
? Ensure that at product launch there are no impediments to reimbursement and return on investment (ROI) can therefore be maximized?
1. Andrew Roddam(GSK)
2. Bruce Crawford(Syneos Health)
평가기준 | 집합 출석율 | 온라인 진도율 | 시험 | 과제 | 토론 | 기타 |
---|---|---|---|---|---|---|
배점비율 | - | 100.00% | - | - | - | - |
과락기준 | - | 100% | - | - | - | - |